Novel role of human epicardial adipocyte-derived SPARCL1 in suppression of postoperative atrial fibrillation in patients undergoing cardiovascular surgery

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Taisuke Harada

Hasama Campus - Faculty of Medicine, Oita University, Yufu City (Japan)

8 More presentations in this session

Presentation thumbnail

Pericardial adipose tissue (PAT) as a cell model to assess patient responsiveness to docosahexaenoic acid (DHA) and eicopentaenoic acid (EPA)

Doctor S. Quarta (Lecce, IT)

Abstract Slides

Presentation thumbnail

Genetically Engineered Clostridium Prevents Perivascular Adipose Tissue and Endothelial Senescence and Dysfunction in Aging

Doctor S. Saeedi (Schlieren, CH)

Abstract Slides

Presentation thumbnail

Semaglutide modulates adipogenic differentiation and extracellular acidification in epicardial (EAT) and subcutaneous (SAT) adipose tissue stromal cells from patients with cardiovascular disease.

Doctor S. Eiras (Santiago de Compostela, ES)

Abstract Slides Video

Presentation thumbnail

Secretomes from human epicardial adipocytes modulate atrial lymphatics and atrial fibrosis

Doctor M. Takahashi (Oita, JP)

Abstract Slides

Presentation thumbnail

Epigenetic modifications in transdifferentiation of adipose tissue-derived stromal cells into spontaneously beating cardiomyocyte-like cells

Mr Y. Shinjo (Kanazawa, JP)

Abstract Slides

Access the full session

Session thumbnail

Adipose tissue and other metabolic interactions

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Session

Risk stratification

Congress Presentation

Anatomical correlates of VF ablation 

Congress Session

Malignant arrhythmias

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources